BOGANI, COSTANZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.368
EU - Europa 2.208
AS - Asia 866
SA - Sud America 100
AF - Africa 22
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.347
PL - Polonia 1.044
RU - Federazione Russa 465
SG - Singapore 221
CN - Cina 215
HK - Hong Kong 157
IT - Italia 150
SE - Svezia 148
IE - Irlanda 129
VN - Vietnam 94
BR - Brasile 79
DE - Germania 70
KR - Corea 57
GB - Regno Unito 42
IN - India 41
FR - Francia 38
FI - Finlandia 37
UA - Ucraina 30
CH - Svizzera 21
JO - Giordania 15
AU - Australia 14
CA - Canada 14
ID - Indonesia 11
TR - Turchia 10
BE - Belgio 9
JP - Giappone 9
BD - Bangladesh 8
NL - Olanda 8
ES - Italia 7
AE - Emirati Arabi Uniti 5
CL - Cile 5
IQ - Iraq 5
MA - Marocco 5
AR - Argentina 4
CI - Costa d'Avorio 4
MX - Messico 4
PK - Pakistan 4
DZ - Algeria 3
EC - Ecuador 3
LT - Lituania 3
ZA - Sudafrica 3
EG - Egitto 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
NP - Nepal 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
Totale 5.580
Salva come PNG Salva come JPEG
Città #
Warsaw 1.043
Santa Clara 573
Ashburn 254
Fairfield 202
Singapore 153
Hong Kong 139
Chandler 137
Dublin 129
Woodbridge 101
Houston 90
Seattle 89
Cambridge 75
Wilmington 72
Beijing 71
San Jose 63
Ann Arbor 59
Seoul 57
Jacksonville 55
Buffalo 40
Ho Chi Minh City 37
Lawrence 33
Altamura 30
Princeton 30
Los Angeles 25
Dallas 23
Florence 23
Bern 21
Boston 21
Lauterbourg 21
Boardman 19
Hefei 19
Hanoi 18
Pune 18
Bremen 15
Dong Ket 15
Mumbai 15
Munich 15
New York 14
Shanghai 14
Melbourne 12
Council Bluffs 10
Phoenix 10
San Diego 10
The Dalles 10
Turku 10
Brussels 9
Frankfurt am Main 9
Medford 9
Jakarta 8
London 8
Moscow 8
Tokyo 8
Milan 7
Clifton 6
Izmir 6
Salerno 6
São Paulo 6
Andover 5
Kent 5
Rignano sull'Arno 5
Santiago 5
Abidjan 4
Abu Dhabi 4
Cagliari 4
Chennai 4
Falls Church 4
Montreal 4
Norwalk 4
Orem 4
Prato 4
Toronto 4
West Jordan 4
Amman 3
Atlanta 3
Basauri 3
Belo Horizonte 3
Brooklyn 3
Cavriago 3
Chicago 3
Dhaka 3
Frankfurt Am Main 3
Guangzhou 3
Hangzhou 3
Hillsboro 3
Manchester 3
Naples 3
Redondo Beach 3
São José dos Campos 3
Sétif 3
Amsterdam 2
Ariano Irpino 2
Baghdad 2
Barcelona 2
Bitonto 2
Biên Hòa 2
Brasília 2
Caldiero 2
Cremona 2
Elk Grove Village 2
Franca 2
Totale 4.117
Salva come PNG Salva come JPEG
Nome #
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial 340
Caratterizzazione di alterazioni molecolari relative alla patogenesi delle Neoplasie Mieloproliferative Croniche 322
Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. 321
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives 320
mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms. 318
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis. 313
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis 307
Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis. 300
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils of polycythemia vera. 279
Overexpression of microRNA-16-2 contributes to the abnormalerythropoiesis in polycythemia vera. 220
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). 219
MicroRNA expression profile in granulocytes from primary myelofibrosis patients. 208
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 201
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines 196
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 194
Inconsistencies in the association between the JAL2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 192
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. 191
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 169
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 164
Preclinical models for drug selection in myeloproliferative neoplasms. 156
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 153
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. 152
JAK PI3K/mTOR COMBINATION THERAPY 141
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis 127
mTOR/JAK INHIBITOR COMBINATION THERAPY 118
Totale 5.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022228 7 12 31 11 9 13 5 16 8 12 47 57
2022/2023572 48 112 26 57 49 93 67 43 40 6 8 23
2023/2024203 6 20 27 18 22 58 3 31 2 2 8 6
2024/20251.432 23 139 86 193 422 256 18 92 59 20 50 74
2025/20261.090 177 160 100 77 149 53 153 44 64 66 32 15
Totale 5.621